Detalhe da pesquisa
1.
Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial.
Lancet
; 399(10324): 541-553, 2022 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123694
2.
Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
Ann Surg Oncol
; 30(1): 35-45, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36085390
3.
Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer.
Gynecol Oncol
; 170: 300-308, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36758420
4.
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.
Lancet
; 394(10214): 2084-2095, 2019 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31791688
5.
[18F]Fluciclatide PET as a biomarker of response to combination therapy of pazopanib and paclitaxel in platinum-resistant/refractory ovarian cancer.
Eur J Nucl Med Mol Imaging
; 47(5): 1239-1251, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31754793
6.
The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer.
EMBO Rep
; 19(8)2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29907679
7.
Risk factors for endometrial cancer: An umbrella review of the literature.
Int J Cancer
; 145(7): 1719-1730, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30387875
8.
Diffusion-weighted MRI in Advanced Epithelial Ovarian Cancer: Apparent Diffusion Coefficient as a Response Marker.
Radiology
; 293(2): 374-383, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31573402
9.
Maximal-Effort Cytoreductive Surgery for Ovarian Cancer Patients with a High Tumor Burden: Variations in Practice and Impact on Outcome.
Ann Surg Oncol
; 26(9): 2943-2951, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31243666
10.
Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study.
Br J Cancer
; 119(7): 815-822, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30206366
11.
Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).
Br J Cancer
; 119(3): 330-338, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29955134
12.
ASO Visual Abstract: Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome, and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer (HGSOC). A Multicenter, Retrospective Study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
Ann Surg Oncol
; 30(1): 46-47, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36335272
13.
Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma.
J Surg Oncol
; 117(2): 236-244, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28787528
14.
Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multicentre study.
Br J Cancer
; 116(10): 1287-1293, 2017 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28350786
15.
Phase Ib study of the mitochondrial inhibitor ME-344 plus topotecan in patients with previously treated, locally advanced or metastatic small cell lung, ovarian and cervical cancers.
Invest New Drugs
; 35(5): 627-633, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28283779
16.
Surgery for Recurrent Uterine Cancer: Surgical Outcomes and Implications for Survival-A Case Series.
Int J Gynecol Cancer
; 27(4): 759-767, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28338493
17.
Integrative Analysis of Subcellular Quantitative Proteomics Studies Reveals Functional Cytoskeleton Membrane-Lipid Raft Interactions in Cancer.
J Proteome Res
; 15(10): 3451-3462, 2016 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27384440
18.
Maximal effort cytoreductive surgery for disseminated ovarian cancer in a UK setting: challenges and possibilities.
Arch Gynecol Obstet
; 294(3): 607-14, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27040418
19.
Risk of Ovarian Cancer Relapse score: a prognostic algorithm to predict relapse following treatment for advanced ovarian cancer.
Int J Gynecol Cancer
; 25(3): 416-22, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25647256
20.
Molecular subtypes of serous borderline ovarian tumor show distinct expression patterns of benign tumor and malignant tumor-associated signatures.
Mod Pathol
; 27(3): 433-42, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23948749